| Secondary |
| Product Used For Unknown Indication |
23.0% |
| Drug Use For Unknown Indication |
17.3% |
| Prophylaxis |
5.8% |
| Rheumatoid Arthritis |
5.8% |
| Hypertension |
4.3% |
| Blood Cholesterol Abnormal |
3.6% |
| Bronchitis |
3.6% |
| Depression |
3.6% |
| Influenza |
3.6% |
| Anxiety |
2.9% |
| Blood Cholesterol Increased |
2.9% |
| Convulsion |
2.9% |
| Hypothyroidism |
2.9% |
| Influenza Immunisation |
2.9% |
| Pain |
2.9% |
| Peritoneal Dialysis |
2.9% |
| Psoriatic Arthropathy |
2.9% |
| Diabetes Mellitus Non-insulin-dependent |
2.2% |
| Gastrooesophageal Reflux Disease |
2.2% |
| High Density Lipoprotein Decreased |
2.2% |
|
| Flushing |
12.2% |
| Nausea |
9.8% |
| Weight Decreased |
9.8% |
| Pneumonia |
7.3% |
| Vomiting |
7.3% |
| Malaise |
4.9% |
| Nasopharyngitis |
4.9% |
| Oropharyngeal Pain |
4.9% |
| Pain |
4.9% |
| Upper Respiratory Tract Congestion |
4.9% |
| Weight Increased |
4.9% |
| Wrong Technique In Drug Usage Process |
4.9% |
| Blood Calcium Decreased |
2.4% |
| Convulsion |
2.4% |
| Cough |
2.4% |
| Dermatitis Acneiform |
2.4% |
| Drug Hypersensitivity |
2.4% |
| Facial Pain |
2.4% |
| Guillain-barre Syndrome |
2.4% |
| Headache |
2.4% |
|
| Concomitant |
| Drug Use For Unknown Indication |
15.4% |
| Multiple Sclerosis |
13.2% |
| Product Used For Unknown Indication |
13.2% |
| Prophylaxis |
8.3% |
| Pain |
5.6% |
| Restless Legs Syndrome |
4.8% |
| Hypertension |
4.4% |
| Rheumatoid Arthritis |
4.2% |
| Asthma |
3.9% |
| Arthritis |
3.4% |
| Blood Cholesterol Increased |
3.1% |
| Arthralgia |
2.6% |
| Diabetes Mellitus |
2.6% |
| Antiviral Prophylaxis |
2.5% |
| Chronic Obstructive Pulmonary Disease |
2.5% |
| Muscle Spasms |
2.5% |
| Depression |
2.2% |
| Anxiety |
2.1% |
| Insomnia |
2.1% |
| Back Pain |
1.6% |
|
| Vomiting |
13.7% |
| Pyrexia |
8.1% |
| Nausea |
7.3% |
| Weight Decreased |
7.3% |
| Multiple Sclerosis Relapse |
5.6% |
| Product Quality Issue |
5.6% |
| Weight Increased |
5.6% |
| Wheezing |
5.6% |
| Dysmorphism |
4.8% |
| Pain |
4.8% |
| Influenza Like Illness |
4.0% |
| Throat Tightness |
4.0% |
| Fatigue |
3.2% |
| Influenza |
3.2% |
| Rash |
3.2% |
| Therapeutic Response Decreased |
3.2% |
| Tremor |
3.2% |
| Feeling Abnormal |
2.4% |
| Nasopharyngitis |
2.4% |
| No Adverse Event |
2.4% |
|
| Interacting |
| Gastrooesophageal Reflux Disease |
60.0% |
| Crohn's Disease |
20.0% |
| Immunisation |
20.0% |
|
| Headache |
75.0% |
| Polyarthritis |
25.0% |
|
